Categories

United States Off–Label Drugs Market & Forecast

US$ 1200

“Off–label prescribing of medicines is prevalent worldwide because it gives freedom to physicians to apply new therapeutic options based on the latest evidence. Although physicians may lawfully prescribe approved Drugs for any use consistent with available scientific data and proper medical practice, but unfortunately, this is done without adequate scientific data.

02-13 2016   Pages: 67

United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast

US$ 1100

“Pediatric Vaccines market for United States is a multi-billion dollar industry. The value of United States pediatric vaccines market alone is expected to reach more than US$ 18 Billion by 2020. The United States Pediatric vaccines market is driven by favorable demographics, growing public acceptance and product innovation. Varicella and Pneumococcal vaccines (PCV) control the highest and second highest market share in United States respectively.

02-13 2016   Pages: 126

Asia Male Condom Users, Market Analysis & Forecast

US$ 1200

Condoms are the third most popular contraceptive method in Asia. China is the largest user of male condoms followed by India and Japan in second and third position in Asia. China has the highest user base due to its large population base.

02-13 2016   Pages: 97

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials – Global

US$ 1290

“Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have captured maximum market share of the Hepatitis C market.

02-13 2016   Pages: 87

Global Osteoporosis Market, Patients, Companies & Forecast

US$ 1100

“Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients.

02-13 2016   Pages: 124

High Intensity Focused Ultrasound – Product Analysis

US$ 900

“High–Intensity Focused Ultrasound (HIFU) is a non–invasive treatment that can destroy tumors with extreme accuracy. Development of technologically advanced HIFU devices, rapid growth in devastating diseases with high risk, growing demand for minimally invasive treatment procedures, and increasing public–private investments are key factors fuelling the growth of the HIFU market.

02-13 2016   Pages: 76

China Molecular Diagnostics Market, Test Volume & Forecast

US$ 1200

China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 – 2019.

02-13 2016   Pages: 84

Global Prostate Cancer Therapeutics Market to 2020

US$ 1200

The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs. Prostate Cancer is the most frequently diagnosed cancer in men.

02-13 2016   Pages: 80

Global Spinal Fusion Market, Procedure Volume and Forecast

US$ 1000

“Spinal fusion is multi Billion dollar market with huge future potential. In 2014 Spinal fusion market was more than US$ 20 Billion. Germany, United States and China are the top three markets (not in the same chronological order) worldwide. In 2014, Spinal fusion procedure volume has crossed over 1 Million.

02-13 2016   Pages: 62

Global CRISPR Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 – 2021

US$ 4000

“Clustered regularly-interspaced short palindromic repeats also known as CRISPR is a gene editing tool. CRIPSR commercialization began in 2012 with emergence of number of startups and venture capitalists and showing their interest in infusing money into this technology. Academic and research firms are the main consumers of CRISPR gene editing tool followed by biotechnology companies.

01-27 2016   Pages: 140
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample